189894-04-0

Basic information

• Product Name: 3-(4-tert-Butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyric acid (3S,5S,8R,9S,10S,13S,14S,17S)-3-[3-(4-tert-butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyryloxy]-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl ester
• Synonyms: 3-(4-tert-Butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyric acid (3S,5S,8R,9S,10S,13S,14S,17S)-3-[3-(4-tert-butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyryloxy]-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl ester
• CAS NO: 189894-04-0
• Molecular Weight: 999.341
• Mol File: 189894-04-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(4-tert-Butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyric acid (3S,5S,8R,9S,10S,13S,14S,17S)-3-[3-(4-tert-butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyryloxy]-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-tert-Butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyric acid (3S,5S,8R,9S,10S,13S,14S,17S)-3-[3-(4-tert-butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyryloxy]-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl ester(189894-04-0)
• EPA Substance Registry System: 3-(4-tert-Butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyric acid (3S,5S,8R,9S,10S,13S,14S,17S)-3-[3-(4-tert-butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyryloxy]-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-yl ester(189894-04-0)

Safety Data

• Hazardous Substances Data: 189894-04-0(Hazardous Substances Data)

Upstream product

• 185049-55-2 3-(4-tert-butylphenyl)glutaric anhydride 
• 185049-53-0 3-(4-tert-butylphenyl)glutaric diacid 
• 571-20-0 5-androgen-3,17-diol 
• 939-97-9 4-tert-Butylbenzaldehyde 

Downstream Products

• 198560-58-6 3-(4-tert-Butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyric acid (3S,5S,6S,8R,9S,10R,13S,14S,17S)-17-[3-(4-tert-butyl-phenyl)-4-(2-sulfo-ethylcarbamoyl)-butyryloxy]-6-hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-yl ester 

Relevant articles and documents

Catalytic oxidations of steroid substrates by artificial cytochrome p-450 enzymes.

Catalysts comprising manganese-porphyrins carrying cyclodextrin binding groups are able to perform hydroxylations with substrate selectivity and regio- and stereoselectivity and high catalytic turnovers. The geometries of the catalyst/substrate complexes override intrinsic substrate reactivities, permitting attack on geometrically accessible saturated carbons of steroids in the presence of secondary carbinol groups and carbon-carbon double bonds, as in enzymatic reactions. Selective hydroxylations of steroid carbon 9 positions are of particular practical interest.